RUA Life Sciences plc (AIM:RUA)

Market Cap	7.84M
Revenue (ttm)	4.11M
Net Income (ttm)	1,000.00
Shares Out	62.06M
EPS (ttm)	0.00
PE Ratio	7,835.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,584
Average Volume	147,706
Open	12.12
Previous Close	12.63
Day's Range	12.00 - 12.63
52-Week Range	10.01 - 15.70
Beta	0.97
RSI	57.60
Earnings Date	Jul 24, 2025

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 40
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: RUA